Cerebrovascular resistance in cognitive aging and Alzheimer's disease risk
$491,520R01FY2022AGNIH
University Of California-Irvine, Irvine CA
Investigators
Linked publications & trials
Paper 39555916Paper 39535349Paper 38946941Paper 38851772Paper 38699510Paper 38699342Paper 38425303Paper 38306042Paper 37485296Paper 37301768Paper 37156179Paper 37154177Paper 37066910Paper 36448621Paper 36370956Paper 36229634Paper 36149821Paper 35923551Paper 35844252Paper 35784272Paper 35487831Paper 35469116Paper 35418462Paper 35325813Paper 34967222Paper 34581957Paper 34250941Paper 34248608Paper 34148364Paper 34034215Paper 33384205Paper 32955459Paper 32925032Paper 32925031Paper 32925030Paper 32830539Paper 32376954Paper 32142126Paper 32070225
Abstract
Project Summary The proposed study will investigate the role of cerebrovascular dysfunction during the earliest stages of neurocognitive decline, prior to any obvious changes in cognition. Specifically, we will study whether cognitively normal older adults at risk for Alzheimer's disease show increased cerebrovascular resistance. We will also study how increased cerebrovascular resistance relates to brain dysfunction using functional brain scans. Finally, we will investigate whether higher cerebrovascular resistance in cognitively normal older adults predicts development of subtle cognitive decline over a two year follow-up interval.
View original record on NIH RePORTER →